Article
AHR-dependent genes and response to MTX therapy in rheumatoid arthritis patients.
The pharmacogenomics journal - 1 Oct 2021
Wajda Anna, Walczuk Ewa, Stypińska Barbara, Lach Jakub, Yermakovich Danat, Sivitskaya Larysa, Romanowska-Próchnicka Katarzyna, Wysocki Tomasz, Jarończyk Małgorzata, Paradowska-Gorycka Agnieszka
Abstract excerpt
Methotrexate (MTX) is the first-line therapy for rheumatoid arthritis. Nevertheless, MTX resistance is quite a common issue in clinical practice. There are some premises that aryl hydrocarbon receptor (AhR) gene battery may take part in MTX metabolism. In the present retrospective study, we analyzed genes expression of AHR genes battery associated with MTX metabolism in whole blood of RA patients with good and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
